Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922 †
Abstract
:Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ayala Gómez, R.; Becerra, M.C.; Pinto Vitorino, G. Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Med. Sci. Forum 2022, 14, 99. https://doi.org/10.3390/ECMC2022-13226
Ayala Gómez R, Becerra MC, Pinto Vitorino G. Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Medical Sciences Forum. 2022; 14(1):99. https://doi.org/10.3390/ECMC2022-13226
Chicago/Turabian StyleAyala Gómez, Rosalía, María Cecilia Becerra, and Graciela Pinto Vitorino. 2022. "Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922" Medical Sciences Forum 14, no. 1: 99. https://doi.org/10.3390/ECMC2022-13226
APA StyleAyala Gómez, R., Becerra, M. C., & Pinto Vitorino, G. (2022). Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Medical Sciences Forum, 14(1), 99. https://doi.org/10.3390/ECMC2022-13226